Healthcare Sector Stocks
The Healthcare sector has a total of 1045 stocks, with a combined market cap of $9.16 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.41.
Market Cap
9.16T
Revenue
4.67T
Profits
189.18B
PE Ratio
48.41
Profit Margin
4.05%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | 0.15% | 1,476,271 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 644.12B | 0.03% | 4,888,657 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 463.89B | -0.20% | 3,118,269 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 357.52B | 0.78% | 7,230,927 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 336.83B | -0.18% | 4,418,330 | 450.53B |
| 6 | NVS | Novartis AG | 265.19B | 0.06% | 1,891,750 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 253.14B | 0.64% | 3,859,290 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 239.76B | 1.10% | 2,880,031 | 46.34B |
| 9 | AMGN | Amgen Inc. | 203.47B | 0.19% | 2,401,881 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 186.08B | -1.93% | 11,669,847 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 183.12B | 0.94% | 5,188,251 | 30.46B |
| 12 | ABT | Abbott Laboratories | 177.12B | 0.32% | 5,229,744 | 46.59B |
| 13 | PFE | Pfizer Inc. | 156.51B | -0.33% | 26,046,157 | 63.70B |
| 14 | DHR | Danaher Corporation | 146.47B | -0.48% | 3,568,836 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 135.05B | 1.36% | 2,135,005 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 130.09B | -0.27% | 638,512 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.92B | -0.20% | 9,449,055 | 49.19B |
| 18 | MDT | Medtronic plc | 118.45B | -1.23% | 10,489,705 | 37.54B |
| 19 | CVS | CVS Health Corporation | 117.31B | -2.93% | 7,235,059 | 412.65B |
| 20 | SYK | Stryker Corporation | 109.23B | 1.16% | 3,399,418 | 25.84B |
| 21 | MCK | McKesson Corporation | 103.45B | -1.36% | 902,280 | 410.98B |
| 22 | SNY | Sanofi | 102.79B | 0.45% | 2,426,874 | 55.89B |
| 23 | GSK | GSK plc | 100.53B | 0.56% | 2,844,570 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 93.19B | 1.75% | 1,369,703 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 89.47B | -1.19% | 1,118,381 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.35B | 0.06% | 382,945 | 15.53B |
| 27 | CI | The Cigna Group | 74.11B | -2.92% | 1,166,262 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 63.64B | 0.09% | 28,476,797 | 21.00B |
| 29 | ARGX | argenx SE | 61.24B | 0.50% | 200,561 | 5.32B |
| 30 | COR | Cencora, Inc. | 60.78B | -1.48% | 931,142 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.20B | -0.32% | 2,952,151 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 58.14B | 1.29% | 8,832,060 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.08B | -0.05% | 1,220,657 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 51.46B | 4.13% | 5,011,766 | 6.51B |
| 35 | NTRA | Natera, Inc. | 49.78B | -1.55% | 1,432,954 | 2.71B |
| 36 | BDX | Becton, Dickinson and Company | 49.53B | -2.19% | 1,734,018 | 22.48B |
| 37 | HUM | Humana Inc. | 46.20B | -3.00% | 1,036,291 | 145.68B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 44.90B | -1.83% | 4,821,843 | 17.32B |
| 39 | IQV | IQVIA Holdings Inc. | 44.25B | -0.32% | 1,671,670 | 16.98B |
| 40 | MDLN | Medline Inc. | 43.37B | 2.74% | 10,943,850 | 29.94B |
| 41 | A | Agilent Technologies, Inc. | 43.33B | 2.28% | 2,507,725 | 7.37B |
| 42 | VEEV | Veeva Systems Inc. | 42.89B | -0.65% | 1,113,732 | 3.46B |
| 43 | RVMD | Revolution Medicines, Inc. | 41.99B | -4.36% | 3,036,953 | - |
| 44 | WAT | Waters Corporation | 41.13B | 0.37% | 710,819 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 40.46B | 0.57% | 376,066 | 4.55B |
| 46 | HLN | Haleon plc | 40.25B | -0.32% | 9,313,825 | 14.80B |
| 47 | ONC | BeOne Medicines AG | 39.58B | 0.46% | 356,695 | 6.13B |
| 48 | ILMN | Illumina, Inc. | 34.57B | 2.99% | 3,375,073 | 4.49B |
| 49 | RPRX | Royalty Pharma plc | 33.62B | - | 2,157,608 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 32.96B | 1.03% | 3,617,181 | 4.97B |
| 51 | RMD | ResMed Inc. | 32.65B | -0.52% | 1,066,869 | 5.65B |
| 52 | CNC | Centene Corporation | 32.61B | -2.44% | 4,278,037 | 180.30B |
| 53 | ALC | Alcon Inc. | 32.52B | -2.15% | 1,709,336 | 10.86B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.03B | 0.46% | 853,904 | 4.80B |
| 55 | BIIB | Biogen Inc. | 31.92B | -0.07% | 606,493 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 30.17B | -0.59% | 4,590,897 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 28.68B | -0.91% | 3,218,579 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 28.58B | 0.18% | 6,181,218 | 7.53M |
| 59 | MTD | Mettler-Toledo International Inc. | 27.62B | 3.63% | 355,610 | 4.13B |
| 60 | DGX | Quest Diagnostics Incorporated | 27.27B | - | 948,753 | 11.56B |
| 61 | INSM | Insmed Incorporated | 26.77B | 2.22% | 1,434,017 | 1.14B |
| 62 | LH | Labcorp Holdings Inc. | 26.32B | 0.17% | 561,399 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.48B | -0.82% | 621,048 | 3.33B |
| 64 | INCY | Incyte Corporation | 25.29B | 2.47% | 1,347,302 | 5.82B |
| 65 | PHG | Koninklijke Philips N.V. | 24.46B | -0.68% | 580,054 | 20.18B |
| 66 | BNTX | BioNTech SE | 24.07B | -0.89% | 407,604 | 3.03B |
| 67 | GH | Guardant Health, Inc. | 23.47B | -0.43% | 1,523,660 | 1.18B |
| 68 | THC | Tenet Healthcare Corporation | 21.40B | 1.89% | 628,988 | 21.81B |
| 69 | UTHR | United Therapeutics Corporation | 21.38B | -0.37% | 488,401 | 3.15B |
| 70 | STE | STERIS plc | 20.47B | -0.18% | 639,522 | 6.04B |
| 71 | GMAB | Genmab A/S | 20.39B | 0.73% | 2,885,965 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.55B | 2.22% | 8,644,933 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.46B | -1.66% | 1,890,471 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.21B | -0.65% | 208,150 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.27B | 3.30% | 1,260,058 | 1.20B |
| 76 | RVTY | Revvity, Inc. | 16.26B | 3.95% | 3,404,321 | 2.91B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.81B | 1.15% | 602,267 | 4.60B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.20B | -0.35% | 1,015,822 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.12B | -1.37% | 978,094 | 8.31B |
| 80 | EXEL | Exelixis, Inc. | 14.07B | -0.21% | 1,879,641 | 2.44B |
| 81 | SMMT | Summit Therapeutics Inc. | 13.80B | -0.57% | 6,087,889 | - |
| 82 | ICLR | ICON Public Limited Company | 13.42B | 0.86% | 818,590 | 8.29B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 13.35B | -0.13% | 4,785,958 | 713.07M |
| 84 | CRL | Charles River Laboratories International, Inc. | 13.05B | 0.19% | 1,014,795 | 4.00B |
| 85 | TEM | Tempus AI, Inc. | 12.63B | 1.63% | 7,585,840 | 1.43B |
| 86 | PEN | Penumbra, Inc. | 12.54B | -0.01% | 816,976 | 1.50B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.53B | 0.43% | 2,252,517 | 3.41B |
| 88 | DVA | DaVita Inc. | 12.36B | 1.55% | 599,325 | 14.01B |
| 89 | HALO | Halozyme Therapeutics, Inc. | 12.31B | 2.06% | 1,709,964 | 1.66B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 12.28B | 0.20% | 1,647,899 | 14.37B |
| 91 | FMS | Fresenius Medical Care AG | 12.24B | 0.04% | 363,864 | 22.19B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.22B | 1.11% | 298,475 | 1.28B |
| 93 | EHC | Encompass Health Corporation | 12.22B | 1.57% | 879,225 | 6.21B |
| 94 | BAX | Baxter International Inc. | 12.16B | -0.76% | 9,453,579 | 11.47B |
| 95 | CORT | Corcept Therapeutics Incorporated | 12.09B | 0.89% | 668,643 | 830.81M |
| 96 | SNN | Smith & Nephew plc | 11.79B | -0.75% | 871,350 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.42B | -0.61% | 7,030,012 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.34B | -0.01% | 3,650,099 | 1.22B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.10B | 3.87% | 644,995 | 776.57M |
| 100 | ALGN | Align Technology, Inc. | 10.69B | 2.35% | 946,514 | 4.14B |
| 101 | UHS | Universal Health Services, Inc. | 10.68B | 2.47% | 881,586 | 18.11B |
| 102 | AVTR | Avantor, Inc. | 10.56B | 1.10% | 10,554,488 | 6.56B |
| 103 | MOH | Molina Healthcare, Inc. | 10.53B | -2.30% | 529,086 | 42.47B |
| 104 | COO | The Cooper Companies, Inc. | 10.38B | 2.52% | 5,314,243 | 4.24B |
| 105 | ENSG | The Ensign Group, Inc. | 10.28B | 2.95% | 485,594 | 5.49B |
| 106 | BIO | Bio-Rad Laboratories, Inc. | 10.13B | 0.27% | 262,414 | 2.59B |
| 107 | GMED | Globus Medical, Inc. | 10.10B | 0.76% | 1,332,691 | 3.14B |
| 108 | OSCR | Oscar Health, Inc. | 9.97B | -0.31% | 6,295,582 | 15.32B |
| 109 | KRYS | Krystal Biotech, Inc. | 9.97B | - | 251,878 | 440.48M |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 9.94B | 1.13% | 2,833,939 | 3.50B |
| 111 | RGEN | Repligen Corporation | 9.76B | -1.04% | 826,903 | 785.10M |
| 112 | PODD | Insulet Corporation | 9.75B | 0.98% | 1,347,087 | 3.05B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.67B | 2.81% | 655,793 | 105.00M |
| 114 | HSIC | Henry Schein, Inc. | 9.67B | -0.86% | 1,018,110 | 13.60B |
| 115 | CYTK | Cytokinetics, Incorporated | 9.65B | 0.12% | 2,211,796 | 67.67M |
| 116 | GKOS | Glaukos Corporation | 9.64B | -4.78% | 690,987 | 612.84M |
| 117 | TXG | 10x Genomics, Inc. | 9.47B | -2.30% | 4,082,635 | 616.91M |
| 118 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.29B | -6.91% | 5,112,415 | 669.50M |
| 119 | BRKR | Bruker Corporation | 9.24B | 8.83% | 4,106,030 | 3.50B |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.24B | -0.39% | 507,312 | 281.99M |
| 121 | ABVX | ABIVAX Société Anonyme | 9.10B | -4.15% | 1,894,356 | 5.67M |
| 122 | TWST | Twist Bioscience Corporation | 8.97B | 3.60% | 2,409,508 | 431.80M |
| 123 | QGEN | Qiagen N.V. | 8.87B | 0.99% | 1,365,690 | 2.10B |
| 124 | PCVX | Vaxcyte, Inc. | 8.75B | -0.74% | 1,249,171 | - |
| 125 | PRAX | Praxis Precision Medicines, Inc. | 8.63B | -1.25% | 545,766 | 7.46M |
| 126 | IBRX | ImmunityBio, Inc. | 8.38B | -2.83% | 9,204,976 | 165.79M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 8.04B | 0.24% | 1,257,642 | - |
| 128 | CAI | Caris Life Sciences, Inc. | 7.97B | -1.02% | 4,302,670 | 989.61M |
| 129 | HQY | HealthEquity, Inc. | 7.94B | -0.53% | 688,358 | 1.36B |
| 130 | ATR | AptarGroup, Inc. | 7.93B | 0.02% | 461,613 | 3.93B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.92B | 5.30% | 2,350,125 | 799.54M |
| 132 | ALKS | Alkermes plc | 7.73B | 0.09% | 1,854,651 | 1.67B |
| 133 | HNGE | Hinge Health, Inc. | 7.56B | 1.45% | 1,797,096 | 720.06M |
| 134 | IMVT | Immunovant, Inc. | 7.51B | -0.74% | 1,169,252 | - |
| 135 | IONS | Ionis Pharmaceuticals, Inc. | 7.45B | -5.10% | 7,958,214 | 874.09M |
| 136 | BLTE | Belite Bio, Inc | 6.81B | -0.14% | 107,338 | - |
| 137 | PACS | PACS Group, Inc. | 6.76B | 1.50% | 1,141,051 | 5.55B |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.75B | 1.28% | 921,422 | 239.92M |
| 139 | CHE | Chemed Corporation | 6.64B | 0.68% | 141,077 | 2.60B |
| 140 | GRFS | Grifols, S.A. | 6.58B | 0.54% | 471,633 | 8.48B |
| 141 | CGON | CG Oncology, Inc. | 6.57B | 2.16% | 795,652 | 6.23M |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.56B | -0.19% | 746,923 | 1.56B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.53B | 0.54% | 7,352,105 | 2.58B |
| 144 | MIRM | Mirum Pharmaceuticals, Inc. | 6.32B | 3.70% | 991,189 | 618.07M |
| 145 | MMED | MiniMed Group, Inc. | 6.30B | 1.77% | 4,068,882 | 3.22B |
| 146 | AMRX | Amneal Pharmaceuticals, Inc. | 6.30B | 8.59% | 5,124,042 | 3.12B |
| 147 | ORKA | Oruka Therapeutics, Inc. | 6.19B | 1.46% | 926,981 | - |
| 148 | STVN | Stevanato Group S.p.A. | 6.15B | 4.60% | 603,505 | 1.40B |
| 149 | LQDA | Liquidia Corporation | 6.13B | 4.15% | 1,296,636 | 450.91M |
| 150 | BLCO | Bausch + Lomb Corporation | 6.10B | -0.93% | 193,999 | 5.32B |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.06B | 3.29% | 553,900 | 840.85M |
| 152 | SRRK | Scholar Rock Holding Corporation | 6.01B | -1.26% | 3,657,747 | - |
| 153 | TVTX | Travere Therapeutics, Inc. | 5.98B | 1.55% | 2,221,346 | 591.33M |
| 154 | RDNT | RadNet, Inc. | 5.96B | -1.74% | 1,176,976 | 2.27B |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 5.73B | -2.18% | 1,035,542 | 1.90M |
| 156 | COGT | Cogent Biosciences, Inc. | 5.65B | -0.61% | 1,921,689 | - |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.64B | 2.96% | 1,397,907 | 1.01B |
| 158 | SHC | Sotera Health Company | 5.52B | 1.84% | 2,838,969 | 1.22B |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.50B | 0.85% | 723,674 | 7.50M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 5.49B | -0.64% | 299,045 | 290.54M |
| 161 | TFX | Teleflex Incorporated | 5.42B | -0.79% | 830,216 | 2.25B |
| 162 | ERAS | Erasca, Inc. | 5.37B | -5.48% | 6,086,163 | - |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.14B | -0.05% | 540,643 | 1.58B |
| 164 | WAY | Waystar Holding Corp. | 5.10B | -0.30% | 3,883,093 | 1.21B |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.09B | 2.80% | 2,069,957 | - |
| 166 | CRSP | CRISPR Therapeutics AG | 5.05B | 0.73% | 2,667,362 | 13.39M |
| 167 | EWTX | Edgewise Therapeutics, Inc. | 4.93B | 4.15% | 1,684,315 | - |
| 168 | BLLN | BillionToOne, Inc. | 4.89B | -0.63% | 398,502 | 397.41M |
| 169 | LFST | LifeStance Health Group, Inc. | 4.89B | -2.07% | 5,250,068 | 1.58B |
| 170 | HAE | Haemonetics Corporation | 4.83B | 0.04% | 520,720 | 1.35B |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 4.75B | 2.91% | 1,405,153 | 1.14B |
| 172 | CON | Concentra Group Holdings Parent, Inc. | 4.64B | 2.11% | 1,092,578 | 2.29B |
| 173 | DOCS | Doximity, Inc. | 4.62B | 0.50% | 2,306,494 | 655.57M |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.56B | 3.25% | 971,054 | 148.00K |
| 175 | IOVA | Iovance Biotherapeutics, Inc. | 4.47B | 5.45% | 19,693,853 | 324.97M |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.42B | 3.71% | 5,026,487 | 308.08M |
| 177 | LIVN | LivaNova PLC | 4.33B | -1.21% | 693,559 | 1.47B |
| 178 | ITGR | Integer Holdings Corporation | 4.29B | -0.08% | 1,124,097 | 1.84B |
| 179 | MANE | Veradermics, Incorporated | 4.28B | -1.41% | 860,434 | - |
| 180 | HTFL | HeartFlow, Inc. | 4.20B | -0.06% | 2,057,378 | 212.07M |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.13B | -0.69% | 2,116,676 | 10.35M |
| 182 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.10B | -1.57% | 1,366,184 | -665.00K |
| 183 | TLX | Telix Pharmaceuticals Limited | 4.09B | -7.79% | 642,226 | 890.79M |
| 184 | INDV | Indivior Pharmaceuticals, Inc. | 4.05B | 0.38% | 1,865,883 | 1.33B |
| 185 | CELC | Celcuity Inc. | 4.04B | -0.15% | 799,305 | - |
| 186 | NVST | Envista Holdings Corporation | 4.01B | 0.97% | 3,556,036 | 2.86B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.94B | -2.26% | 2,835,545 | 53.81M |
| 188 | ICUI | ICU Medical, Inc. | 3.89B | -0.17% | 193,643 | 2.16B |
| 189 | ABCL | AbCellera Biologics Inc. | 3.78B | 2.28% | 4,544,984 | 66.17M |
| 190 | IRTC | iRhythm Holdings, Inc. | 3.69B | -0.05% | 479,691 | 825.34M |
| 191 | OPCH | Option Care Health, Inc. | 3.67B | 4.04% | 3,715,278 | 5.69B |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 3.64B | 0.19% | 639,913 | 234.13M |
| 193 | ELVN | Enliven Therapeutics, Inc. | 3.60B | -7.95% | 2,914,714 | - |
| 194 | OGN | Organon & Co. | 3.59B | 0.07% | 2,072,473 | 6.13B |
| 195 | PLSE | Pulse Biosciences, Inc. | 3.54B | -10.13% | 1,037,138 | 1.19M |
| 196 | NHC | National HealthCare Corporation | 3.53B | -0.55% | 72,005 | 1.56B |
| 197 | VKTX | Viking Therapeutics, Inc. | 3.44B | -1.44% | 3,009,486 | - |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.41B | -0.75% | 658,806 | 606.33M |
| 199 | GRAL | GRAIL, Inc. | 3.35B | -1.03% | 1,615,181 | 165.26M |
| 200 | LEGN | Legend Biotech Corporation | 3.29B | -3.79% | 3,527,110 | 1.27B |
| 201 | ARQT | Arcutis Biotherapeutics, Inc. | 3.29B | 11.19% | 5,156,099 | 463.98M |
| 202 | DYN | Dyne Therapeutics, Inc. | 3.23B | -3.32% | 2,156,022 | - |
| 203 | DNLI | Denali Therapeutics Inc. | 3.21B | -1.57% | 1,855,650 | 3.60M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.14B | 1.36% | 2,295,534 | 117.00M |
| 205 | AVAH | Aveanna Healthcare Holdings Inc. | 3.11B | -0.35% | 4,811,888 | 2.60B |
| 206 | VCYT | Veracyte, Inc. | 3.10B | -4.09% | 1,622,368 | 561.90M |
| 207 | CLDX | Celldex Therapeutics, Inc. | 3.04B | 0.52% | 1,001,441 | 158.00K |
| 208 | TMDX | TransMedics Group, Inc. | 3.04B | -0.60% | 464,755 | 668.47M |
| 209 | MBX | MBX Biosciences, Inc. | 2.97B | 0.80% | 1,159,832 | - |
| 210 | QURE | uniQure N.V. | 2.95B | -1.42% | 1,469,946 | 18.67M |
| 211 | GRDN | Guardian Pharmacy Services, Inc. | 2.95B | -3.08% | 836,810 | 1.46B |
| 212 | WRBY | Warby Parker Inc. | 2.91B | -3.25% | 3,468,364 | 911.61M |
| 213 | ATRC | AtriCure, Inc. | 2.91B | 1.64% | 1,216,890 | 569.62M |
| 214 | WGS | GeneDx Holdings Corp. | 2.91B | 2.94% | 791,988 | 454.43M |
| 215 | RGC | Regencell Bioscience Holdings Limited | 2.81B | 1.43% | 127,997 | - |
| 216 | BKD | Brookdale Senior Living Inc. | 2.79B | -1.52% | 3,341,598 | 2.93B |
| 217 | CDNA | CareDx, Inc. | 2.77B | 1.73% | 846,283 | 458.09M |
| 218 | ZLAB | Zai Lab Limited | 2.77B | -0.52% | 1,158,231 | 449.61M |
| 219 | NEOG | Neogen Corporation | 2.74B | 2.45% | 2,838,620 | 870.40M |
| 220 | AXGN | Axogen, Inc. | 2.67B | 1.05% | 1,423,861 | 251.17M |
| 221 | IMNM | Immunome, Inc. | 2.66B | -2.05% | 1,317,970 | 4.02M |
| 222 | PGEN | Precigen, Inc. | 2.66B | 6.21% | 8,226,555 | 85.72M |
| 223 | PHVS | Pharvaris N.V. | 2.64B | -1.34% | 829,000 | - |
| 224 | IRON | Disc Medicine, Inc. | 2.63B | 1.89% | 433,917 | - |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.62B | 2.85% | 1,232,301 | 3.37B |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.61B | 1.29% | 1,236,383 | 36.77M |
| 227 | PRVA | Privia Health Group, Inc. | 2.60B | 0.05% | 1,411,788 | 2.36B |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.54B | 2.79% | 1,671,904 | 71.13M |
| 229 | NAMS | NewAmsterdam Pharma Company N.V. | 2.53B | 0.09% | 1,238,524 | 7.12M |
| 230 | GPCR | Structure Therapeutics Inc. | 2.53B | -8.86% | 1,649,191 | - |
| 231 | HRMY | Harmony Biosciences Holdings, Inc. | 2.46B | 0.09% | 1,599,209 | 959.90M |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.43B | -4.74% | 1,415,499 | - |
| 233 | NEO | NeoGenomics, Inc. | 2.43B | 0.26% | 1,621,185 | 766.30M |
| 234 | CLOV | Clover Health Investments, Corp. | 2.42B | -2.15% | 3,843,908 | 2.48B |
| 235 | SUPN | Supernus Pharmaceuticals, Inc. | 2.41B | 0.24% | 787,815 | 830.44M |
| 236 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | 3.28% | 5,126,237 | - |
| 237 | BEAM | Beam Therapeutics Inc. | 2.31B | -0.52% | 1,821,041 | 156.04M |
| 238 | NKTR | Nektar Therapeutics | 2.30B | 1.11% | 986,116 | 54.59M |
| 239 | VERA | Vera Therapeutics, Inc. | 2.29B | -5.64% | 3,911,880 | - |
| 240 | HCM | HUTCHMED (China) Limited | 2.27B | -2.39% | 31,208 | 549.12M |
| 241 | AUPH | Aurinia Pharmaceuticals Inc. | 2.26B | 5.15% | 1,171,705 | 311.51M |
| 242 | TRLV | Trulieve Cannabis Corp. | 2.22B | -0.43% | 1,670,540 | 1.14B |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.22B | 0.39% | 536,931 | 1.10B |
| 244 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 0.14% | 201,973 | - |
| 245 | ADUS | Addus HomeCare Corporation | 2.17B | 2.27% | 190,713 | 1.48B |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.17B | -3.14% | 3,405,745 | 52.06M |
| 247 | UFPT | UFP Technologies, Inc. | 2.16B | 1.43% | 94,654 | 631.64M |
| 248 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.15B | 3.31% | 5,860,007 | 940.61M |
| 249 | TRVI | Trevi Therapeutics, Inc. | 2.14B | -0.20% | 2,277,364 | - |
| 250 | BHC | Bausch Health Companies Inc. | 2.13B | 0.35% | 1,565,815 | 10.85B |
| 251 | URGN | UroGen Pharma Ltd. | 2.13B | 4.19% | 997,161 | 188.73M |
| 252 | ESTA | Establishment Labs Holdings Inc. | 2.12B | -0.45% | 211,850 | 245.82M |
| 253 | ZBIO | Zenas BioPharma, Inc. | 2.11B | 1.22% | 746,409 | 1.00M |
| 254 | INSP | Inspire Medical Systems, Inc. | 2.10B | -2.48% | 845,864 | 898.74M |
| 255 | PGNY | Progyny, Inc. | 2.10B | -1.37% | 864,466 | 1.31B |
| 256 | SRPT | Sarepta Therapeutics, Inc. | 2.09B | -4.63% | 2,509,698 | 1.97B |
| 257 | MD | Pediatrix Medical Group, Inc. | 2.07B | -2.10% | 629,320 | 1.95B |
| 258 | VCEL | Vericel Corporation | 2.06B | 1.23% | 490,484 | 306.30M |
| 259 | KOD | Kodiak Sciences Inc. | 2.06B | -0.67% | 707,944 | - |
| 260 | ALMR | Alamar Biosciences, Inc. | 2.04B | 2.19% | 469,449 | 100.42M |
| 261 | NUVB | Nuvation Bio Inc. | 2.03B | -0.34% | 2,781,413 | 169.90M |
| 262 | XRAY | DENTSPLY SIRONA Inc. | 2.02B | 3.15% | 5,509,652 | 3.64B |
| 263 | GENB | Generate Biomedicines, Inc. | 2.01B | -3.15% | 1,510,379 | 26.48M |
| 264 | ADMA | ADMA Biologics, Inc. | 1.99B | 3.37% | 2,766,577 | 512.28M |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.99B | -3.02% | 387,026 | 20.00M |
| 266 | AGIO | Agios Pharmaceuticals, Inc. | 1.97B | 0.43% | 863,621 | 98.34M |
| 267 | BFLY | Butterfly Network, Inc. | 1.93B | -6.92% | 5,162,470 | 112.14M |
| 268 | ASTH | Astrana Health, Inc. | 1.93B | -1.69% | 263,463 | 3.84B |
| 269 | COAG | Hemab Therapeutics Holdings, Inc. | 1.91B | 2.14% | 597,199 | - |
| 270 | CMPS | COMPASS Pathways plc | 1.91B | -0.07% | 1,987,437 | - |
| 271 | MESO | Mesoblast Limited | 1.91B | -2.24% | 243,837 | 120.25M |
| 272 | GHRS | GH Research PLC | 1.90B | 0.73% | 152,949 | - |
| 273 | FTRE | Fortrea Holdings Inc. | 1.90B | 1.22% | 2,689,866 | 2.68B |
| 274 | NVCR | NovoCure Limited | 1.89B | 0.43% | 1,639,363 | 699.19M |
| 275 | PRGO | Perrigo Company plc | 1.88B | -0.15% | 2,105,784 | 4.14B |
| 276 | SNDA | Sonida Senior Living, Inc. | 1.87B | -0.66% | 331,919 | 481.07M |
| 277 | ZYME | Zymeworks Inc. | 1.86B | 0.73% | 686,993 | 37.13M |
| 278 | LMAT | LeMaitre Vascular, Inc. | 1.84B | 0.17% | 256,910 | 262.43M |
| 279 | ALVO | Alvotech | 1.82B | 1.59% | 3,867,633 | 494.61M |
| 280 | BHVN | Biohaven Ltd. | 1.82B | -2.59% | 2,253,127 | - |
| 281 | SGRY | Surgery Partners, Inc. | 1.81B | 2.05% | 1,477,081 | 3.37B |
| 282 | ALHC | Alignment Healthcare, Inc. | 1.81B | -16.01% | 24,341,346 | 4.58B |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.80B | -0.85% | 592,030 | 27.59M |
| 284 | LKFT | Lakefront Biotherapeutics NV | 1.80B | -1.40% | 415,608 | 1.13B |
| 285 | SEPN | Septerna, Inc. | 1.79B | -1.08% | 304,947 | 98.88M |
| 286 | SDGR | Schrödinger, Inc. | 1.79B | 2.92% | 2,804,463 | 259.04M |
| 287 | VIR | Vir Biotechnology, Inc. | 1.78B | 0.77% | 2,091,091 | 303.23M |
| 288 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.78B | -0.58% | 3,080,948 | 208.78M |
| 289 | BLFS | BioLife Solutions, Inc. | 1.77B | -0.77% | 467,818 | 106.69M |
| 290 | XNCR | Xencor, Inc. | 1.76B | -0.17% | 1,230,467 | 104.97M |
| 291 | BRVE | Braveheart Bio, Inc. | 1.76B | 2.77% | 550,673 | - |
| 292 | NBTX | Nanobiotix S.A. | 1.76B | -2.44% | 198,703 | 38.27M |
| 293 | PSNL | Personalis, Inc. | 1.72B | 0.06% | 2,255,890 | 69.67M |
| 294 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | -1.54% | 14,813,898 | 54.86M |
| 295 | TYRA | Tyra Biosciences, Inc. | 1.67B | -4.25% | 1,138,620 | - |
| 296 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | 0.20% | 4,346,869 | 5.49M |
| 297 | KLRA | Kailera Therapeutics, Inc. | 1.65B | -5.58% | 1,134,935 | - |
| 298 | IMCR | Immunocore Holdings plc | 1.63B | -0.60% | 460,268 | 430.78M |
| 299 | ATEC | Alphatec Holdings, Inc. | 1.62B | -1.50% | 2,730,049 | 815.05M |
| 300 | KARD | Kardigan, Inc. | 1.62B | -6.73% | 986,911 | - |
| 301 | ETON | Eton Pharmaceuticals, Inc. | 1.61B | 2.59% | 336,214 | 105.60M |
| 302 | NTLA | Intellia Therapeutics, Inc. | 1.61B | 1.14% | 4,590,886 | 59.51M |
| 303 | ANAB | AnaptysBio, Inc. | 1.61B | -0.68% | 394,072 | 232.39M |
| 304 | FRNM | Freenome, Inc. | 1.58B | 0.61% | 423,972 | 35.41M |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.58B | 2.05% | 431,595 | 978.38M |
| 306 | SNDX | Syndax Pharmaceuticals, Inc. | 1.54B | -4.48% | 2,332,306 | 252.25M |
| 307 | NVAX | Novavax, Inc. | 1.54B | 1.30% | 2,849,468 | 413.80M |
| 308 | AVLN | Avalyn Pharma Inc. | 1.54B | 1.25% | 244,455 | - |
| 309 | INVA | Innoviva, Inc. | 1.53B | 1.73% | 715,398 | 440.00M |
| 310 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | 0.22% | 438,885 | - |
| 311 | DMRA | Damora Therapeutics, Inc. | 1.51B | -0.89% | 1,241,833 | - |
| 312 | ARDT | Ardent Health, Inc. | 1.51B | 0.28% | 565,581 | 6.41B |
| 313 | AGL | agilon health, inc. | 1.51B | -2.67% | 165,120 | 5.92B |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.50B | -0.09% | 632,906 | 1.86B |
| 315 | INBX | Inhibrx Biosciences, Inc. | 1.50B | -3.64% | 363,492 | 1.30M |
| 316 | NUTX | Nutex Health Inc. | 1.49B | 0.93% | 146,855 | 846.72M |
| 317 | PNTG | The Pennant Group, Inc. | 1.48B | 6.28% | 1,135,587 | 1.10B |
| 318 | INNV | InnovAge Holding Corp. | 1.48B | -0.64% | 221,724 | 989.71M |
| 319 | OMCL | Omnicell, Inc. | 1.48B | -0.61% | 439,352 | 1.25B |
| 320 | BCAX | Bicara Therapeutics Inc. | 1.46B | -2.96% | 798,331 | - |
| 321 | AZTA | Azenta, Inc. | 1.45B | 0.54% | 729,673 | 613.81M |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.43B | -4.37% | 825,014 | 106.73M |
| 323 | PAHC | Phibro Animal Health Corporation | 1.43B | 0.77% | 269,517 | 1.52B |
| 324 | KRSA | Korsana Biosciences, Inc. | 1.42B | -2.65% | 35,504 | - |
| 325 | XERS | Xeris Biopharma Holdings, Inc. | 1.42B | 3.87% | 2,035,032 | 335.41M |
| 326 | CNMD | CONMED Corporation | 1.41B | 0.19% | 296,755 | 1.37B |
| 327 | AAPG | Ascentage Pharma Group International | 1.41B | -3.75% | 3,904 | 94.61M |
| 328 | TRAX | First Tracks Biotherapeutics, Inc. | 1.39B | 1.38% | 637,185 | - |
| 329 | DRTS | Alpha Tau Medical Ltd. | 1.39B | 1.14% | 671,585 | - |
| 330 | ABSI | Absci Corporation | 1.38B | 1.26% | 2,613,667 | 1.56M |
| 331 | LBRX | LB Pharmaceuticals Inc | 1.37B | -1.09% | 231,920 | - |
| 332 | AVBP | ArriVent BioPharma, Inc. | 1.36B | -1.14% | 379,431 | - |
| 333 | AMN | AMN Healthcare Services, Inc. | 1.35B | 2.25% | 552,012 | 3.43B |
| 334 | MAZE | Maze Therapeutics, Inc. | 1.33B | -1.30% | 385,689 | 20.00M |
| 335 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | 0.44% | 825,812 | - |
| 336 | SVRA | Savara Inc. | 1.30B | -2.47% | 1,127,049 | - |
| 337 | ORIC | ORIC Pharmaceuticals, Inc. | 1.30B | 1.46% | 1,609,373 | - |
| 338 | VOR | Vor Biopharma Inc. | 1.30B | -1.66% | 1,496,853 | - |
| 339 | HROW | Harrow, Inc. | 1.28B | 1.09% | 461,133 | 275.59M |
| 340 | RARE | Ultragenyx Pharmaceutical Inc. | 1.27B | -1.45% | 5,031,175 | 717.00M |
| 341 | AKTS | Aktis Oncology, Inc. | 1.26B | 1.34% | 855,045 | 10.06M |
| 342 | OMER | Omeros Corporation | 1.26B | 0.99% | 2,108,105 | 38.42M |
| 343 | IART | Integra LifeSciences Holdings Corporation | 1.25B | 2.36% | 1,618,120 | 1.65B |
| 344 | USPH | U.S. Physical Therapy, Inc. | 1.24B | 2.01% | 173,940 | 804.27M |
| 345 | CERT | Certara, Inc. | 1.24B | -3.21% | 3,914,671 | 421.75M |
| 346 | MGTX | MeiraGTx Holdings plc | 1.23B | - | 917,361 | 397.50M |
| 347 | CRON | Cronos Group Inc. | 1.22B | 2.81% | 1,051,704 | 179.09M |
| 348 | REPL | Replimune Group, Inc. | 1.22B | -0.54% | 1,810,810 | - |
| 349 | AORT | Artivion, Inc. | 1.22B | -1.42% | 683,245 | 471.47M |
| 350 | TNDM | Tandem Diabetes Care, Inc. | 1.22B | 7.68% | 3,866,508 | 1.04B |
| 351 | OMDA | Omada Health, Inc. | 1.21B | 0.46% | 887,019 | 309.76M |
| 352 | OPK | OPKO Health, Inc. | 1.20B | 2.55% | 2,289,302 | 587.90M |
| 353 | SPTX | Seaport Therapeutics, Inc. | 1.19B | -3.57% | 235,897 | - |
| 354 | IMTX | Immatics N.V. | 1.18B | 0.47% | 711,875 | 47.65M |
| 355 | ANRO | Alto Neuroscience, Inc. | 1.18B | -0.83% | 548,383 | - |
| 356 | TDOC | Teladoc Health, Inc. | 1.17B | -2.28% | 2,752,357 | 2.49B |
| 357 | GDRX | GoodRx Holdings, Inc. | 1.16B | -2.87% | 721,568 | 785.23M |
| 358 | MNKD | MannKind Corporation | 1.14B | -0.28% | 2,228,279 | 393.63M |
| 359 | APMD | Apnimed, Inc. | 1.13B | 5.99% | 552,569 | 115.12M |
| 360 | STAA | STAAR Surgical Company | 1.12B | -0.18% | 711,151 | 339.59M |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -1.02% | 305,177 | 1.04B |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.11B | 0.73% | 1,295,765 | 337.34M |
| 363 | BVS | Bioventus Inc. | 1.11B | 1.54% | 546,024 | 581.85M |
| 364 | ODTX | Odyssey Therapeutics, Inc. | 1.11B | 5.14% | 591,376 | 99.00K |
| 365 | CSTL | Castle Biosciences, Inc. | 1.08B | -0.06% | 559,270 | 357.28M |
| 366 | GLUE | Monte Rosa Therapeutics, Inc. | 1.08B | -2.62% | 1,496,070 | 28.73M |
| 367 | ENOV | Enovis Corporation | 1.08B | 4.01% | 1,812,206 | 2.30B |
| 368 | MLTX | MoonLake Immunotherapeutics | 1.06B | 2.13% | 2,600,600 | - |
| 369 | OBX | Obsidian Therapeutics, Inc. | 1.06B | 0.88% | 1,167,025 | - |
| 370 | JBIO | Jade Biosciences, Inc. | 1.06B | -4.20% | 1,730,474 | - |
| 371 | IRMD | IRADIMED CORPORATION | 1.06B | 0.21% | 115,966 | 86.34M |
| 372 | SLBT | SL Science Holding Limited | 1.03B | -5.24% | 129,373 | 3.27M |
| 373 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | -5.56% | 952,275 | - |
| 374 | ALMS | Alumis Inc. | 1.03B | -5.48% | 4,800,650 | 7.40M |
| 375 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.02B | 1.31% | 503,881 | 730.02M |
| 376 | ATTO | Attovia Therapeutics, Inc. | 1.02B | -6.12% | 293,374 | 1.80M |
| 377 | GMRS | GMR Solutions Inc. | 1.01B | 1.89% | 2,377,877 | 5.88B |
| 378 | ANL | Adlai Nortye Group Ltd. | 999.46M | 3.47% | 220,825 | 18.06M |
| 379 | ABUS | Arbutus Biopharma Corporation | 999.13M | -0.20% | 4,009,391 | 181.72M |
| 380 | BBNX | Beta Bionics, Inc. | 997.87M | 15.34% | 7,193,454 | 119.01M |
| 381 | KURA | Kura Oncology, Inc. | 996.36M | -0.88% | 1,793,131 | 77.23M |
| 382 | JANX | Janux Therapeutics, Inc. | 993.17M | -1.19% | 1,161,649 | 24.00M |
| 383 | PCRX | Pacira BioSciences, Inc. | 992.96M | 3.45% | 759,129 | 746.16M |
| 384 | HELP | Cybin Inc. | 984.12M | 2.67% | 928,170 | - |
| 385 | SGP | SpyGlass Pharma, Inc. | 956.61M | -1.24% | 186,220 | - |
| 386 | CBLL | CeriBell, Inc. | 940.26M | -2.16% | 461,682 | 101.96M |
| 387 | SLDB | Solid Biosciences Inc. | 935.00M | 4.18% | 2,256,406 | - |
| 388 | IVA | Inventiva S.A. | 903.84M | -1.81% | 2,219,652 | 7.94M |
| 389 | HSTM | HealthStream, Inc. | 900.13M | -0.78% | 181,002 | 321.12M |
| 390 | LXRX | Lexicon Pharmaceuticals, Inc. | 898.81M | 0.50% | 2,151,591 | 41.47M |
| 391 | AVTX | Avalo Therapeutics, Inc. | 889.19M | 3.17% | 1,444,896 | 59.00K |
| 392 | WVE | Wave Life Sciences, Inc. | 887.70M | 1.01% | 2,990,804 | 65.37M |
| 393 | FTH | Faeth Therapeutics, Inc. | 884.78M | -3.19% | 572,403 | - |
| 394 | TBPH | Theravance Biopharma, Inc. | 884.18M | -0.06% | 461,692 | 104.31M |
| 395 | SANA | Sana Biotechnology, Inc. | 874.13M | -7.59% | 9,724,428 | - |
| 396 | IMMX | Immix Biopharma, Inc. | 852.75M | -1.81% | 1,421,938 | - |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 851.35M | -0.51% | 1,247,711 | - |
| 398 | ARDX | Ardelyx, Inc. | 844.75M | -0.29% | 5,377,949 | 450.89M |
| 399 | CADL | Candel Therapeutics, Inc. | 843.23M | -0.90% | 1,168,699 | - |
| 400 | INMD | InMode Ltd. | 838.07M | -1.95% | 958,189 | 374.63M |
| 401 | SIBN | SI-BONE, Inc. | 830.94M | -0.05% | 411,381 | 213.60M |
| 402 | RIGL | Rigel Pharmaceuticals, Inc. | 830.88M | 0.27% | 226,406 | 276.79M |
| 403 | GERN | Geron Corporation | 828.79M | -1.53% | 11,439,985 | 204.56M |
| 404 | AVR | Anteris Technologies Global Corp. | 815.73M | 0.36% | 968,155 | 2.24M |
| 405 | CLYM | Climb Bio, Inc. | 810.43M | 1.44% | 2,622,125 | - |
| 406 | BLSM | BlossomHill Therapeutics, Inc. | 804.40M | 18.40% | 319,960 | - |
| 407 | AHCO | AdaptHealth Corp. | 788.45M | 1.55% | 2,534,263 | 3.36B |
| 408 | ACRS | Aclaris Therapeutics, Inc. | 783.10M | -3.80% | 5,771,579 | 8.22M |
| 409 | DSGN | Design Therapeutics, Inc. | 782.58M | 2.25% | 985,135 | - |
| 410 | VREX | Varex Imaging Corporation | 778.47M | - | 671,257 | 865.00M |
| 411 | ACHV | Achieve Life Sciences, Inc. | 763.54M | 1.37% | 1,905,747 | - |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 760.16M | 0.95% | 819,577 | 92.01M |
| 413 | GLAS | Glass House Brands Inc. | 756.77M | -0.12% | 545,937 | 176.98M |
| 414 | SLN | Silence Therapeutics plc | 752.62M | 0.32% | 983,807 | 615.00K |
| 415 | PHAR | Pharming Group N.V. | 750.09M | 0.47% | 58,028 | 366.48M |
| 416 | ANNX | Annexon, Inc. | 745.05M | 0.26% | 4,515,069 | - |
| 417 | QDEL | QuidelOrtho Corporation | 738.56M | 1.32% | 1,667,660 | 2.67B |
| 418 | CBIO | Crescent Biopharma, Inc. | 735.32M | -8.62% | 528,913 | 11.88M |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 722.41M | 1.60% | 1,154,222 | 808.21M |
| 420 | DBVT | DBV Technologies S.A. | 715.71M | 0.26% | 159,078 | 5.04M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 712.56M | -0.23% | 136,416 | - |
| 422 | GYRE | Gyre Therapeutics, Inc. | 710.43M | 0.15% | 126,370 | 109.82M |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 700.73M | 1.29% | 795,113 | 136.07M |
| 424 | AURA | Aura Biosciences, Inc. | 697.93M | -2.75% | 1,294,176 | - |
| 425 | NGNE | Neurogene Inc. | 693.79M | 2.91% | 232,132 | 925.00K |
| 426 | MDXG | MiMedx Group, Inc. | 689.45M | 0.21% | 1,094,841 | 355.17M |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 689.05M | 2.71% | 1,312,800 | 389.32M |
| 428 | MNPR | Monopar Therapeutics Inc. | 680.95M | -2.76% | 90,410 | - |
| 429 | SOPH | SOPHiA GENETICS SA | 678.89M | 0.19% | 1,490,342 | 86.17M |
| 430 | STLN | Starling Oncology, Inc. | 665.51M | 2.51% | 1,388,438 | 587.24M |
| 431 | VSTM | Verastem, Inc. | 662.92M | -0.27% | 1,452,335 | 87.53M |
| 432 | SSII | SS Innovations International, Inc. | 655.26M | -0.91% | 79,595 | 52.40M |
| 433 | SGMT | Sagimet Biosciences Inc. | 650.18M | - | 620,559 | - |
| 434 | CTKB | Cytek Biosciences, Inc. | 640.82M | 0.82% | 1,555,260 | 206.71M |
| 435 | ANGO | AngioDynamics, Inc. | 639.00M | -1.40% | 469,643 | 320.17M |
| 436 | AHG | Akso Health Group | 638.33M | -1.96% | 9,662 | 13.83M |
| 437 | PHR | Phreesia, Inc. | 635.61M | -1.06% | 553,802 | 507.79M |
| 438 | MPLT | MapLight Therapeutics, Inc. | 633.56M | -5.63% | 613,867 | - |
| 439 | OABI | OmniAb, Inc. | 632.45M | - | 1,064,669 | 38.46M |
| 440 | ALT | Altimmune, Inc. | 630.24M | 0.31% | 3,331,820 | 31.00K |
| 441 | VALN | Valneva SE | 625.88M | 0.31% | 35,684 | 163.30M |
| 442 | OCS | Oculis Holding AG | 611.76M | -1.59% | 314,098 | 1.45M |
| 443 | PHAT | Phathom Pharmaceuticals, Inc. | 610.82M | -5.76% | 2,072,506 | 239.66M |
| 444 | CRMD | CorMedix Inc. | 609.52M | 0.77% | 664,712 | 462.25M |
| 445 | AQST | Aquestive Therapeutics, Inc. | 604.97M | 0.21% | 1,351,944 | 54.09M |
| 446 | KIDS | OrthoPediatrics Corp. | 604.44M | -0.39% | 186,781 | 252.72M |
| 447 | CTMX | CytomX Therapeutics, Inc. | 602.49M | 2.79% | 6,868,696 | 18.30M |
| 448 | FLGT | Fulgent Genetics, Inc. | 595.16M | 1.64% | 328,323 | 323.93M |
| 449 | STTK | Shattuck Labs, Inc. | 590.14M | -1.51% | 743,057 | 1.00M |
| 450 | WEAV | Weave Communications, Inc. | 585.59M | -0.14% | 2,466,089 | 257.79M |
| 451 | ALLO | Allogene Therapeutics, Inc. | 583.88M | -1.74% | 5,648,085 | 4.64M |
| 452 | DRUG | Bright Minds Biosciences Inc. | 582.64M | -1.84% | 97,447 | - |
| 453 | EVO | Evotec SE | 575.95M | - | 24,916 | 819.47M |
| 454 | CTEV | Claritev Corporation | 568.76M | -5.57% | 99,129 | 994.67M |
| 455 | DCTH | Delcath Systems, Inc. | 562.81M | 0.31% | 463,167 | 95.42M |
| 456 | AGMB | AgomAb Therapeutics NV | 561.92M | -6.17% | 120,333 | - |
| 457 | PROK | ProKidney Corp. | 559.30M | 6.32% | 1,813,747 | 818.00K |
| 458 | SCTX | Scribe Therapeutics Inc. | 550.91M | -8.09% | 326,039 | 33.30M |
| 459 | TECX | Tectonic Therapeutic, Inc. | 545.62M | -2.10% | 188,421 | - |
| 460 | BWAY | BrainsWay Ltd. | 542.62M | - | 88,879 | 60.70M |
| 461 | TLRY | Tilray Brands, Inc. | 538.38M | -1.50% | 3,831,708 | 915.45M |
| 462 | PRME | Prime Medicine, Inc. | 533.71M | -4.46% | 3,292,945 | 4.07M |
| 463 | ARVN | Arvinas, Inc. | 533.55M | -1.21% | 742,625 | 316.70M |
| 464 | EPRX | Eupraxia Pharmaceuticals Inc. | 532.96M | -0.25% | 197,604 | - |
| 465 | EOLS | Evolus, Inc. | 527.74M | 1.01% | 683,412 | 316.49M |
| 466 | RGNX | REGENXBIO Inc. | 526.79M | 0.38% | 1,231,602 | 174.48M |
| 467 | OVID | Ovid Therapeutics Inc. | 523.40M | -1.11% | 1,428,324 | 1.58M |
| 468 | ASMB | Assembly Biosciences, Inc. | 518.79M | -2.41% | 348,789 | 74.85M |
| 469 | CTNM | Contineum Therapeutics, Inc. | 517.67M | -0.43% | 785,962 | - |
| 470 | ENTX | Entera Bio Ltd. | 512.50M | 3.50% | 777,611 | 42.00K |
| 471 | CERS | Cerus Corporation | 509.86M | 1.20% | 1,455,624 | 221.55M |
| 472 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 473 | TCMD | Tactile Systems Technology, Inc. | 502.20M | -1.51% | 445,335 | 350.31M |
| 474 | AUTL | Autolus Therapeutics plc | 497.72M | -1.06% | 1,915,098 | 117.39M |
| 475 | CAPR | Capricor Therapeutics, Inc. | 497.67M | - | 2,386,177 | 11.13M |
| 476 | NRC | NRC Health | 487.74M | 0.41% | 72,072 | 140.00M |
| 477 | PBYI | Puma Biotechnology, Inc. | 484.71M | 1.51% | 188,832 | 231.24M |
| 478 | NPCE | NeuroPace, Inc. | 483.97M | -1.05% | 116,145 | 106.99M |
| 479 | SENS | Senseonics Holdings, Inc. | 479.04M | 2.03% | 739,236 | 48.55M |
| 480 | DNA | Ginkgo Bioworks Holdings, Inc. | 475.42M | 1.00% | 976,218 | 132.42M |
| 481 | KMDA | Kamada Ltd. | 475.38M | 1.24% | 128,016 | 191.85M |
| 482 | VOGX | Vogenx, Inc. | 464.71M | 3.66% | 97,585 | - |
| 483 | SRTA | Strata Critical Medical, Inc. | 461.80M | -1.32% | 525,812 | 255.98M |
| 484 | EIKN | Eikon Therapeutics, Inc. | 460.94M | -10.33% | 989,385 | - |
| 485 | PRLD | Prelude Therapeutics Incorporated | 460.39M | -1.11% | 191,573 | 22.42M |
| 486 | RLMD | Relmada Therapeutics, Inc. | 450.15M | -4.95% | 824,376 | - |
| 487 | IRD | Opus Genetics, Inc. | 450.09M | -7.04% | 2,335,162 | 9.86M |
| 488 | SGHT | Sight Sciences, Inc. | 448.42M | 0.37% | 168,276 | 83.38M |
| 489 | ARCT | Arcturus Therapeutics Holdings Inc. | 443.40M | -1.52% | 851,437 | 29.37M |
| 490 | ZURA | Zura Bio Limited | 441.77M | -6.49% | 1,269,762 | - |
| 491 | INDP | Indaptus Therapeutics, Inc. | 427.71M | -11.81% | 1,200,628 | - |
| 492 | KYTX | Kyverna Therapeutics, Inc. | 426.72M | -0.86% | 685,754 | - |
| 493 | CCCC | C4 Therapeutics, Inc. | 424.44M | 0.58% | 2,320,846 | 35.04M |
| 494 | PRTA | Prothena Corporation plc | 423.02M | -1.08% | 398,337 | 54.53M |
| 495 | EVH | Evolent Health, Inc. | 422.84M | - | 1,404,539 | 2.10B |
| 496 | CABA | Cabaletta Bio, Inc. | 422.17M | -4.05% | 6,144,877 | - |
| 497 | IKT | Inhibikase Therapeutics, Inc. | 420.59M | - | 370,503 | 1.00 |
| 498 | ARTV | Artiva Biotherapeutics, Inc. | 420.46M | -3.48% | 516,988 | 251.00K |
| 499 | CARL | Carlsmed, Inc. | 418.00M | 0.53% | 55,058 | 63.30M |
| 500 | PACB | Pacific Biosciences of California, Inc. | 416.51M | - | 5,319,722 | 159.27M |